Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 16|pp. 20716–20737
N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions
Back to articleFigure 7(7 of 7)
100%
Figure 7
Figure 7.Expression differences on m6A-related regulators between APOE ɛ4+ and APOE ɛ4− groups. (A–E) Five representative DEGs between two groups. *p < 0.05, **p < 0.01, ***p < 0.001.